Research

And Grants

Note: When clicking the "Submit Grant Application" button below you will be redirected to SnapGrant.com to complete the application process.

Submit Grant Application

Home > Research and Grants

The Cure Starts Now follows an extensive grant approval process to ensure your dollars make the biggest impact to homerun cancer research. Take comfort in knowing that The Cure Starts Now only funds: research that follows our mission, research that is non-duplicative, and research that is financially sound.

The Cure Starts Now has funded $24,934,877 (USD) in pediatric brain cancer research in partnership with the DIPG / DMG Collaborative. This includes 161 grants at over 100 hospitals in 29 countries.




Funding of PBTCF 2019: PBTC-058 - $25,000

Amount
$25,000.00
Date
January 2019

PBTC-058: Phase 2 Study of Intraventricular Omburtamab-based Radioimmunotherapy for Pediatric Patients with Recurrent Medulloblastoma and Ependymoma

Grant Information

Sydney Children’s Hospital - $175,089

Amount
$175,089.00
Date
November 2018

Polyamine Pathway Metabolism as a Novel Therapeutic Option for Diffuse Intrinsic Pontine Glioma

Grant Information

Cincinnati Children's Hospital - $540,742

Amount
$540,742.00
Date
November 2018

Expansion of the International DIPG Registry.

Grant Information

Bambino Gesú Children's Hospital - $99,382

Amount
$99,382.00
Date
November 2018

Investigating the Role of DIPG-Derived Exosomes in Tumor Growth and Invasion.

Grant Information

Ann and Robert H. Lurie Children's Hospital of Chicago - $35,000

Amount
$35,000.00
Date
November 2018

Credentialing an Improved DIPG Mouse Model.

Grant Information

Oncoceutics ONC201 - $83,333

Amount
$83,333.00
Date
October 2018

Expansion of the ONC201 Compassionate Use.

Grant Information
Learn More

The Institute of Cancer Research - $100,000

Amount
$100,000.00
Date
October 2018

Short-pulse Ultrasound Delivery of Panobinostat for the Treatment of Diffuse Intrinsic Gliomas in Children

Grant Information

The Institute of Cancer Research - $106,647

Amount
$106,647.00
Date
October 2018

A Mouse Model of HIST1H3B/ACVR1 Mutant DIPG.

Grant Information

Johns Hopkins Children's Center - $50,000

Amount
$50,000.00
Date
July 2018

Using Zebrafish to Accelerate DIPG Drug Development.

Grant Information

Funding of PBTCF 2018: PBTC-058 - $16,800

Amount
$16,800.00
Date
January 2018

PBTC-058: Phase 2 Study of Intraventricular Omburtamab-based Radioimmunotherapy for Pediatric Patients with Recurrent Medulloblastoma and Ependymoma

Grant Information

The Campbell Family Institute for Cancer Research - $100,000

Amount
$100,000.00
Date
October 2017

Defining the molecular mechanisms of DIPG development and progression to uncover novel therapeutic targets

Grant Information

Institute of Cancer Research - $102,432

Amount
$102,432.00
Date
October 2017

Combinational strategies alongside ACVR1 inhibition in DIPG

Grant Information

The Regents of the University of California - $70,000

Amount
$70,000.00
Date
October 2017

An Open Label Single Arm Phase I/II study of MTX110 delivered by convection-enhanced delivery (CED) in patients with diffuse intrinsic pontine glioma (DIPG) previously treated with external beam radiation therapy

Grant Information

The Hospital for Sick Children - $100,560

Amount
$100,560.00
Date
October 2017

MRI Guided Focused Ultrasound: Towards Clinical Translation in Diffuse Intrinsic Pontine Glioma (DIPG)

Grant Information

Texas Children's Hospital and Ann & Robert H. Lurie Children's Hospital of Chicago - $200,000

Amount
$200,000.00
Date
October 2017

Targeting DIPG through Combining a Super-activator (MCB-613) of Steroid Receptor Co-activators with Radiation.

Grant Information